Loading...

CERS CERUS CORP US FDA Inspections 8-K Filing

CRS

CRS

CERUS CORP

(CERS)

2024 8-K

Management Change

Financial Results Announced

Director Retirement

Revenue Announcement

Record Q3 Results

Financial Statements

Financial Statements

Financial Results

Director Departure

Supply Agreement

Q3 Financial Results

Program Updates

Financial Results Announcement

Appointment of Director

Annual Meeting Approval

Financial Results

Other Special Situation

Financial Results Announcement

Results of Operations and F...

Loan Agreement Amendment an...

Earnings Reports

Earnings Reports

Annual Meeting Summary

Financial Results Announcement

Credit Agreements

Results of Operations and F...

Financial Results

External Links:

Cerus Corp announces positive results of Phase 3 clinical trial for INTERCEPT Blood System in cardiovascular surgery patients.

AI Assistant

CERUS CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.